ICTRP Search Portal

Main

Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.

Register:	CTRI
Last refreshed on:	24 November 2021
Main ID:	CTRI/2018/01/011295
Date of registration:	12-01-2018
Prospective Registration:	No
Primary sponsor:	Sanofi India Limited
Public title:	An Observational survey on Management of Allergic Rhinitis by Physicians and Patient.
Scientific title:	Unmet needs in allergic rhinitis: International Survey on Management of Allergic Rhinitis by Physician and Patient - ISMAR 2
Date of first enrolment:	22-02-2013
Target sample size:	2367
Recruitment status:	Completed
URL:	http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=6152
Study type:	Observational
Study design:	Other Method of generating randomization sequence:Not Applicable Method of allocation concealment:Not Applicable Blinding and masking:Not Applicable
Phase:	N/A

Countries of recruitment
Algeria	Egypt	India	Iran (Islamic Republic of)	Kuwait	Pakistan	Qatar	Saudi Arabia
United Arab Emirates

Contacts

Name:	Dr Mohit Trivedi
Address:	3rd Floor, Sanofi House, CTS No.117-B, L&T Business Park, Saki Vihar Road, Powai Mumbai, India 400 072 Mumbai, MAHARASHTRA India
Telephone:	02230707800
Email:	Deepa.Chodankar@sanofi.com
Affiliation:	Sanofi (India) Limited

Name:	Dr Deepa Chodankar
Address:	3rd Floor, CSU, Sanofi House, CTS No.117-B, L&T Business Park, Saki Vihar Road, Powai Mumbai 400 072 Mumbai, MAHARASHTRA India
Telephone:	02230707800
Email:	Deepa.Chodankar@sanofi.com
Affiliation:	Sanofi (India) Limited

Key inclusion & exclusion criteria

Inclusion criteria: 1. Male or female, adults or children (>= 6 years) with a rhinitis diagnosed by a physician since at least one year.

2. Outpatient visiting their physician for whatever reason.

3. Informed Consent obtained prior to any study procedures.

Exclusion criteria: 1. Current participation in any clinical trial

2. Inability to complete patientâ??s questionnaire

Age minimum:
Age maximum:
Gender:

Health Condition(s) or Problem(s) studied

Health Condition 1: null- Allergic Rhinitis Health Condition 2: J309- Allergic rhinitis, unspecified

Intervention(s)

Primary Outcome(s)

To explore rhinitis attitudes and treatment practices among separate groups of physicians and patients, with the goal of identifying barriers to optimal management and revealing limitations of currently available treatments.Timepoint: Visit 1

Secondary Outcome(s)

1. To identify country/local features that may determine some therapeutic decisions (e.g., type of center, medication availability/cost, laboratory tests, traditions, geographical constrainsâ?¦).

2. To estimate the impact of guidelines â??in real lifeâ?? management of rhinitis and the quality of physicianâ??patient communication

3. To enhance treatment compliance and outcomesTimepoint: Visit 1

Secondary ID(s)

DIREGR06411, version no 1.0, dated 10 July 2012

Source(s) of Monetary Support

Sanofi India Limited, Sanofi House, CTS No.117-B, L&T Business Park, Saki Vihar Road, Powai Mumbai, India 400072

Secondary Sponsor(s)

Ethics review